The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Breakdown of Novo Nordisk pharmaceutical group's revenue in 2022, by product category
Novo Nordisk: sales breakdown by product type 2022
This statistic presents the distribution of Novo Nordisk's revenue in 2022 by product category. Novo Nordisk is a Danish pharmaceutical group operating internationally and is headquartered in Bagsværd, near Copenhagen. The company specializes in treatments for diabetes, as well as hemostasis, growth hormone, and hormone therapies. Novo Nordisk was formed in 1989 from the merger of two Danish pharmaceutical companies: Novo Industri and Nordisk Gentofte. Established in France since 1961, Novo Nordisk maintains a production site in Chartres that produces insulin cartridges. The assembly and packaging of insulin injection pens also take place there. In 2022, sales of diabetes treatments generated ** percent of Novo Nordisk's revenue.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Novo Nordisk: Revenue by Geographic Region 2022
- Premium Statistic Novo Nordisk Group Global Revenue 2007-2024
- Premium Statistic R&D costs of Novo Nordisk as share of sales 2009-2024
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Basic Statistic Operating profit (EBIT) of Sobi 2009-2024
- Basic Statistic Profit of Sobi 2009-2024
- Basic Statistic Gross profit of Sobi 2009-2024
- Basic Statistic Employees at Sobi 2013-2024
- Premium Statistic Net sales of insulin medications of Novo Nordisk in Greater China 2022, by type
- Premium Statistic Net sales of diabetes medicines of Novo Nordisk in Greater China 2022, by product
About the region
10
- Basic Statistic Novo Nordisk operating profit 2009-2025
- Basic Statistic Share of sales outside Denmark of Novo Nordisk 2008-2024
- Premium Statistic Net profit margin of Novo Nordisk 2016-2025
- Basic Statistic Net sales of Novo Nordisk Q1 2021-Q4 2025
- Premium Statistic Novo Nordisk sales of leading products 2025
- Premium Statistic Funding for contraception research and development (R&D) worldwide in 2018
- Premium Statistic Funding for human papillomavirus (HPV) research and development (R&D) worldwide 2018
- Basic Statistic Projection of top global pharmaceutical products by revenue growth 2023
- Basic Statistic Worldwide biopharma M&A transaction volume by location 2015-2019
- Basic Statistic Percentage return on R&D among mid cap biopharma companies 2013-2020
Selected statistics
10
- Premium Statistic Novo Nordisk net profit 2009-2025
- Basic Statistic Revenue of Sobi 2009-2024
- Premium Statistic Employment at select top pharmaceutical companies in Denmark 2025
- Basic Statistic Novo Nordisk sales in diabetes subsegments 2025
- Premium Statistic R&D costs of Novo Nordisk 2018-2025
- Premium Statistic Leading pharmaceutical companies in Denmark 2025, by revenue
- Premium Statistic Novo Nordisk sales share by therapy area 2021-2025
- Basic Statistic Novo Nordisk net sales 2009-2025
- Basic Statistic Wegovy sales of Novo Nordisk Q1 2022-Q1 2026
- Premium Statistic Novo Nordisk sales share by region 2025
Other regions
9
- Premium Statistic Net sales of diabetes medicines of Novo Nordisk in Greater China 2022, by type
- Premium Statistic Share of Novo Nordisk in insulin market in Greater China 2019, by segment
- Basic Statistic Share of drug dispensing costs in select public drug plans Canada 2017-2021
- Basic Statistic Plan-paid share of Rx drug expenditures in Canada by public plan 2021/2022
- Basic Statistic Total patented drugs for human use in Canada in 2023 by introduction time
- Basic Statistic Drug products patented sales in Canada by therapeutic class 2022
- Basic Statistic Average price ratio of patented drugs in Canada 2022 and year of introduction
- Basic Statistic Patented drug products annual sales in Canada 1990-2023
- Basic Statistic Patented drug products annual sales change in Canada 1991-2023
Related statistics
10
- Basic Statistic Share of drug costs by type in public drug plans Canada 2014/15 to 2021/22
- Basic Statistic Share of prescriptions by drug type in public drug plans Canada 2014-2022
- Basic Statistic New NASs reviewed by medicine prices review board Canada 2014-2021 by improvement
- Premium Statistic Italy: perception of pharmaceutical companies 2018, by brand
- Premium Statistic Operating profit Celltrion 2017-2024
- Premium Statistic Sales revenue Yuhan 2023, by sector
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Basic Statistic New drugs patented for human use distribution in Canada 1989-2023
- Basic Statistic Number of public drug plan beneficiaries in Canada by province 2020/2021
- Basic Statistic Drug products patented sales share in Canada, by therapeutic class 2022
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Novo Nordisk. (January 31, 2023). Breakdown of Novo Nordisk pharmaceutical group's revenue in 2022, by product category [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 01, 2026, from /statistics/1638292/novo-nordisk-sales-breakdown-by-product-2022/
Novo Nordisk. "Breakdown of Novo Nordisk pharmaceutical group's revenue in 2022, by product category." Chart. January 31, 2023. ÌÇÐÄÆƽâ°æ. Accessed August 01, 2026. /statistics/1638292/novo-nordisk-sales-breakdown-by-product-2022/
Novo Nordisk. (2023). Breakdown of Novo Nordisk pharmaceutical group's revenue in 2022, by product category. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 01, 2026. /statistics/1638292/novo-nordisk-sales-breakdown-by-product-2022/
Novo Nordisk. "Breakdown of Novo Nordisk Pharmaceutical Group's Revenue in 2022, by Product Category." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 31 Jan 2023, /statistics/1638292/novo-nordisk-sales-breakdown-by-product-2022/
Novo Nordisk, Breakdown of Novo Nordisk pharmaceutical group's revenue in 2022, by product category ÌÇÐÄÆƽâ°æ, /statistics/1638292/novo-nordisk-sales-breakdown-by-product-2022/ (last visited August 01, 2026)
Breakdown of Novo Nordisk pharmaceutical group's revenue in 2022, by product category [Graph], Novo Nordisk, January 31, 2023. [Online]. Available: /statistics/1638292/novo-nordisk-sales-breakdown-by-product-2022/
Advertisement